|
PDP1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.579200E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.408000E-01 |
| Normal-vs-Stage2 |
8.699200E-01 |
| Normal-vs-Stage3 |
3.861400E-01 |
| Normal-vs-Stage4 |
1.832790E-01 |
| Stage1-vs-Stage2 |
4.396400E-01 |
| Stage1-vs-Stage3 |
9.359200E-01 |
| Stage1-vs-Stage4 |
4.613800E-01 |
| Stage2-vs-Stage3 |
4.238400E-01 |
| Stage2-vs-Stage4 |
2.190000E-01 |
| Stage3-vs-Stage4 |
5.205400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.551000E-01 |
| Normal-vs-AfricanAmerican |
2.679000E-01 |
| Normal-vs-Asian |
8.421900E-02 |
| Caucasian-vs-AfricanAmerican |
4.264000E-01 |
| Caucasian-vs-Asian |
2.736400E-01 |
| AfricanAmerican-vs-Asian |
8.772200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
8.094200E-01 |
| Normal-vs-Female |
1.713770E-01 |
| Male-vs-Female |
3.154800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.041600E-02 |
| Normal-vs-Age(41-60Yrs) |
6.116800E-01 |
| Normal-vs-Age(61-80Yrs) |
6.927600E-01 |
| Normal-vs-Age(81-100Yrs) |
3.295000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.154420E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.267800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.482600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.943600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.751400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.615400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
3.071600E-01 |
| Classical-VS-Follicular |
2.33420005546492E-09 |
| Classical-VS-Other |
1.504370E-01 |
| Classical-VS-Normal |
1.216060E-02 |
| Tall-VS-Follicular |
2.41700000003231E-06 |
| Tall-VS-Other |
3.114400E-02 |
| Tall-VS-Normal |
7.664400E-03 |
| Follicular-VS-Other |
7.425800E-01 |
| Follicular-VS-Normal |
2.962800E-03 |
| Other-VS-Normal |
2.815600E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.863800E-01 |
| Normal-vs-N1 |
1.449050E-01 |
| N0-vs-N1 |
3.186300E-02 |
|
|
